David Plotkin

1.4k total citations
21 papers, 828 citations indexed

About

David Plotkin is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, David Plotkin has authored 21 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Cancer Research and 3 papers in Pathology and Forensic Medicine. Recurrent topics in David Plotkin's work include Cancer Treatment and Pharmacology (6 papers), Breast Cancer Treatment Studies (6 papers) and Estrogen and related hormone effects (3 papers). David Plotkin is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Breast Cancer Treatment Studies (6 papers) and Estrogen and related hormone effects (3 papers). David Plotkin collaborates with scholars based in United States and Canada. David Plotkin's co-authors include Bernard Fisher, Carol Redmond, Edwin R. Fisher, J Wolter, Norman Wolmark, David M. J. S. Bowman, Rafael Bornstein, S Legault-Poisson, A Brown and Jeffrey Wilkins and has published in prestigious journals such as The Lancet, JAMA and Journal of Clinical Oncology.

In The Last Decade

David Plotkin

21 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Plotkin United States 14 306 280 195 106 101 21 828
G. C. RENNIE Australia 17 146 0.5× 234 0.8× 116 0.6× 218 2.1× 226 2.2× 30 1.3k
Michael M. Ritter Germany 18 124 0.4× 196 0.7× 131 0.7× 52 0.5× 206 2.0× 43 1.2k
Thérèse Lemarchand-Béraud Switzerland 17 94 0.3× 74 0.3× 130 0.7× 50 0.5× 147 1.5× 27 957
W S Campbell United States 13 407 1.3× 153 0.5× 329 1.7× 248 2.3× 216 2.1× 14 1.1k
Cheng-Chun Lee Taiwan 23 175 0.6× 95 0.3× 76 0.4× 112 1.1× 308 3.0× 53 1.2k
Maureen O’Connell United States 17 69 0.2× 152 0.5× 44 0.2× 134 1.3× 87 0.9× 20 983
Sergio Crispino Italy 18 376 1.2× 160 0.6× 96 0.5× 49 0.5× 233 2.3× 61 1.1k
David W Purdie United Kingdom 15 448 1.5× 148 0.5× 546 2.8× 208 2.0× 253 2.5× 37 1.2k
T J Benraad Netherlands 18 139 0.5× 111 0.4× 125 0.6× 25 0.2× 177 1.8× 37 870
Yoram Cohen Israel 18 271 0.9× 115 0.4× 280 1.4× 96 0.9× 483 4.8× 47 1.3k

Countries citing papers authored by David Plotkin

Since Specialization
Citations

This map shows the geographic impact of David Plotkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Plotkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Plotkin more than expected).

Fields of papers citing papers by David Plotkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Plotkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Plotkin. The network helps show where David Plotkin may publish in the future.

Co-authorship network of co-authors of David Plotkin

This figure shows the co-authorship network connecting the top 25 collaborators of David Plotkin. A scholar is included among the top collaborators of David Plotkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Plotkin. David Plotkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Plotkin, David, et al.. (2009). Heel Neuroma: A Case Study. The Journal of Foot & Ankle Surgery. 48(3). 376–379. 5 indexed citations
2.
Wilkins, Jeffrey, et al.. (2004). DHEAS and POMS measures identify cocaine dependence treatment outcome. Psychoneuroendocrinology. 30(1). 18–28. 30 indexed citations
3.
Gorp, Wilfred G. van, et al.. (2000). Nicotine Dependence and Withdrawal in Cocaine-Dependent Patients. Archives of General Psychiatry. 57(5). 512–512. 1 indexed citations
4.
Gorp, Wilfred G. van, Jeffrey Wilkins, Charles H. Hinkin, et al.. (1999). Declarative and Procedural Memory Functioning in Abstinent Cocaine Abusers. Archives of General Psychiatry. 56(1). 85–85. 83 indexed citations
5.
Plotkin, David & Francis G. Blankenberg. (1991). Breast Cancer–Biology and Malpractice. American Journal of Clinical Oncology. 14(3). 254–269. 15 indexed citations
6.
Fisher, Bernard, Carol Redmond, A Brown, et al.. (1986). Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial.. Journal of Clinical Oncology. 4(4). 459–471. 162 indexed citations
7.
Bennett, John M., Patrick J. Byrne, Ajit Desai, et al.. (1985). A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer. Investigational New Drugs. 3(2). 179–185. 15 indexed citations
8.
Bertram, Juergen H., Steven M. Grunberg, Ira Shulman, et al.. (1985). Staphylococcal Protein A column: correlation of mitogenicity of perfused plasma with clinical response.. PubMed. 45(9). 4486–94. 14 indexed citations
9.
Klein, Leonard M., et al.. (1983). Thymidine and 5-FU: a Phase II pilot study in colorectal and breast carcinomas.. PubMed. 67(7-8). 735–6. 4 indexed citations
10.
Fisher, Bernard, Carol Redmond, D. Lawrence Wickerham, et al.. (1983). Relation of estrogen and/or progesterone receptor content of breast cancer to patient outcome following adjuvant chemotherapy. Breast Cancer Research and Treatment. 3(4). 355–364. 25 indexed citations
11.
Plotkin, David & W.J. Waugh. (1983). Hypothesis. American Journal of Clinical Oncology. 6(3). 375–380. 9 indexed citations
12.
Plotkin, David, et al.. (1982). Toxicity of single- vs. fractionated-dose ifosfamide in non-small cell lung cancer: a multi-center study.. PubMed. 9(4 Suppl 1). 66–70. 31 indexed citations
13.
Plotkin, David, et al.. (1982). Biological studies in adult attention deficit disorder: case report.. PubMed. 43(12). 501–2. 4 indexed citations
14.
Plotkin, David, et al.. (1982). Single-dose ifosfamide: efficacy studies in non-small cell lung cancer.. PubMed. 9(4 Suppl 1). 56–60. 20 indexed citations
15.
Glass, Andrew G., Wieand Hs, Bernard Fisher, et al.. (1981). Acute toxicity during adjuvant chemotherapy for breast cancer: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience from 1717 patients receiving single and multiple agents.. PubMed. 65(5-6). 363–76. 28 indexed citations
16.
Plotkin, David. (1978). Tamoxifen Flare in Advanced Breast Cancer. JAMA. 240(24). 2644–2644. 110 indexed citations
17.
Fisher, Bernard, Andrew G. Glass, Carol Redmond, et al.. (1977). L-phenylalanine mustard (L-PAM) in the management of primary breast cancer:An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU). Cancer. 39(6). 2883–2903. 117 indexed citations
18.
Dayton, Seymour, et al.. (1968). CONTROLLED TRIAL OF A DIET HIGH IN UNSATURATED FAT FOR PREVENTION OF ATHEROSCLEROTIC COMPLICATIONS. The Lancet. 292(7577). 1060–1062. 128 indexed citations
19.
Sawitsky, Arthur & David Plotkin. (1955). Hypofibrinogenemia and postpartum hemorrhage.. PubMed. 55(8). 1153–8. 2 indexed citations
20.
Plotkin, David, et al.. (1953). The development of total blindness as a complication of pregnancy. American Journal of Obstetrics and Gynecology. 66(3). 641–647. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. C. RENNIE Breakdown of academic impact, for papers by Michael M. Ritter Breakdown of academic impact, for papers by Thérèse Lemarchand-Béraud Breakdown of academic impact, for papers by W S Campbell Breakdown of academic impact, for papers by Cheng-Chun Lee Breakdown of academic impact, for papers by Maureen O’Connell Breakdown of academic impact, for papers by Sergio Crispino Breakdown of academic impact, for papers by David W Purdie Breakdown of academic impact, for papers by T J Benraad Breakdown of academic impact, for papers by Yoram Cohen
Rankless by CCL
2026